CSPC Pharmaceutical Group Limited (FRA:CVG)

Market Cap	11.30B
Revenue (ttm)	3.09B
Net Income (ttm)	458.27M
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	24.66
Forward PE	17.26
Dividend	0.03 (2.79%)
Ex-Dividend Date	Oct 17, 2025

Volume	3,283
Average Volume	1,442
Open	0.9534
Previous Close	1.0030
Day's Range	0.9534 - 0.9534
52-Week Range	0.5158 - 1.2490
Beta	n/a
RSI	46.02
Earnings Date	Nov 21, 2025

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 21,400
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVG

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY